Aldehyde dehydrogenase 2 Glu504Lys variant predicts a worse prognosis of acute coronary syndrome patients

Aldehyde dehydrogenase 2 (ALDH2) Glu504Lys variant was an independent risk factor for acute coronary syndrome (ACS). However, there are lacking researches about the relationship between the variant and prognosis of ACS. In the prospective study, 377 ACS patients were grouped into the wild‐type (*1/*...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Cell Mol Med
Egile Nagusiak: Pan, Chang, Zhao, Yu, Bian, Yuan, Shang, Rui, Wang, Jia‐li, Xue, Li, Wei, Shu‐jian, Zhang, He, Chen, Yu‐guo, Xu, Feng
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2018
Gaiak:
Short Communications
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5867093/
https://ncbi.nlm.nih.gov/pubmed/29441687
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.13536
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak